Literature DB >> 689839

The initiation, progress, and diagnosis of dog bladder cancer induced by 4-aminobiphenyl.

N L Block, M M Sigel, C M Lynne, A B Ng, R A Grosberg.   

Abstract

Twenty-four beagles received 4-aminobiphenyl orally 5 days a week for 3 years. The dogs were examined cytoscopically at frequent intervals. Biopsy and surgery were performed according to predetermined criteria. Three basic patterns of carcinogen responses were seen. Negative or minimal disease was seen in four dogs. Of these, two remained completely free of neoplasia. Eleven dogs progressed slowly in their development of neoplasia with minor fluctuations in development. A rapidly progressive pattern was observed in the remaining nine dogs. A large variance in the time of onset of the first positive diagnosis of neoplasia was seen. Eleven dogs underwent surgery ranging from tumor sampling to cystectomy plus ureterosigmoidostomy. Histologic types and grades and patterns of metastasis as well as several other characteristics seemed to parallel closely human bladder cancer.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 689839

Source DB:  PubMed          Journal:  Invest Urol        ISSN: 0021-0005


  4 in total

1.  Identification of an unintended consequence of Nrf2-directed cytoprotection against a key tobacco carcinogen plus a counteracting chemopreventive intervention.

Authors:  Joseph D Paonessa; Yi Ding; Kristen L Randall; Rex Munday; Dayana Argoti; Paul Vouros; Yuesheng Zhang
Journal:  Cancer Res       Date:  2011-04-12       Impact factor: 12.701

2.  Sulforaphane inhibits 4-aminobiphenyl-induced DNA damage in bladder cells and tissues.

Authors:  Yi Ding; Joseph D Paonessa; Kristen L Randall; Dayana Argoti; Lihua Chen; Paul Vouros; Yuesheng Zhang
Journal:  Carcinogenesis       Date:  2010-09-01       Impact factor: 4.944

Review 3.  Non‑infective occupational risk factors for hepatocellular carcinoma: A review (Review).

Authors:  Caterina Ledda; Carla Loreto; Christian Zammit; Andrea Marconi; Lucrezia Fago; Serena Matera; Valentina Costanzo; Giovanni Fuccio Sanzà; Stefano Palmucci; Margherita Ferrante; Chiara Costa; Concettina Fenga; Antonio Biondi; Cristoforo Pomara; Venerando Rapisarda
Journal:  Mol Med Rep       Date:  2016-12-14       Impact factor: 2.952

4.  Application of biomarkers to risk assessment.

Authors:  D W Gaylor; F F Kadlubar; F A Beland
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.